AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation by the European Commission (EC) to be used as a ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BRIMICA GENUAIR 340/12 contains the active ingredient aclidinium ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BRETARIS GENUAIR contains the active ingredient aclidinium bromide.
European regulators have given the all clear to Almirall's Eklira Genuair to help alleviate the symptoms of chronic obstructive pulmonary disease (COPD), hot on the heels of a US green light. European ...
The specific attributes of inhaler devices can influence patient use, satisfaction and treatment compliance, and may ultimately impact on clinical outcomes in patients with chronic obstructive ...
MISSISSAUGA, ON, Oct. 31, 2013 /CNW/ - Almirall Canada announced the Health Canada approval of Tudorza™ Genuair™ (aclidinium bromide) as a long-term maintenance bronchodilator treatment in patients ...
This is the fifth territorial licensing agreement for Aclidinium. Previous partnerships have been established in the US, Japan, Korea and Europe Aclidinium, a new therapeutic option for Chronic ...
European Commission approves Eklira/Bretaris Genuair as maintenance bronchodilator treatment of COPD
Almirall S.A. (ALM), an international pharma company based on innovation and committed to health, has received the European Commission marketing approval to Eklira/Bretaris Genuair(aclidinium 322µg ...
--Data to be presented at 2010 American Thoracic Society International Conference-- NEW YORK--(BUSINESS WIRE)-- Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM.MC) today announced that ...
AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation by the European Commission (EC) to be used as a ...
Almirall S.A. (ALM) announced today that the European Commission has granted marketing approval to Eklira/Bretaris Genuair ® (aclidinium 322µg twice daily) in all EU member states, plus Iceland and ...
--Data to be presented at 2010 American Thoracic Society International Conference-- NEW YORK--(BUSINESS WIRE)-- Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM.MC) today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results